Alar Applies to FDA for ALA-3000 Depression Trial
Alar Pharmaceuticals submitted an application to the U.S. FDA for a clinical trial of ALA-3000 for depression.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.